314 related articles for article (PubMed ID: 27066808)
21. Etoposide and immunotherapy can improve the outcome of severe anti-GABAB R encephalitis presenting with delta brush: A case report.
Xiping W; Guomin X; Haifeng W; Qi S; Liping Z
Medicine (Baltimore); 2020 Sep; 99(37):e22087. PubMed ID: 32925748
[TBL] [Abstract][Full Text] [Related]
22. [Patients with anti-GABA (B) receptor encephalitis: 8 cases report].
Zhang J; Li J; Pang BX; Wen XM; Guo L
Zhonghua Yi Xue Za Zhi; 2019 Jul; 99(25):1985-1988. PubMed ID: 31269606
[No Abstract] [Full Text] [Related]
23. [Successful combination immunotherapy of anti-gamma aminobutyric acid (GABA)
Fukami Y; Okada H; Yoshida M; Yamaguchi K
Rinsho Shinkeigaku; 2017 Aug; 57(8):436-440. PubMed ID: 28740064
[TBL] [Abstract][Full Text] [Related]
24. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.
Vincent A; Buckley C; Schott JM; Baker I; Dewar BK; Detert N; Clover L; Parkinson A; Bien CG; Omer S; Lang B; Rossor MN; Palace J
Brain; 2004 Mar; 127(Pt 3):701-12. PubMed ID: 14960497
[TBL] [Abstract][Full Text] [Related]
25. LGI1 antibody encephalitis - Detailed clinical, laboratory and radiological description of 13 cases in China.
Wang D; Hao Q; He L; He L; Wang Q
Compr Psychiatry; 2018 Feb; 81():18-21. PubMed ID: 29195105
[TBL] [Abstract][Full Text] [Related]
26. [Anti-N-methyl-D-aspartate receptor encephalitis in seven children].
Wang XH; Fang F; Ding CH; Lü JL; Han TL; Liu LY; Li JW; Wu Y; Cui LY; Ren HT; Xu CL
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):885-9. PubMed ID: 23324141
[TBL] [Abstract][Full Text] [Related]
27. Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.
Höftberger R; van Sonderen A; Leypoldt F; Houghton D; Geschwind M; Gelfand J; Paredes M; Sabater L; Saiz A; Titulaer MJ; Graus F; Dalmau J
Neurology; 2015 Jun; 84(24):2403-12. PubMed ID: 25979696
[TBL] [Abstract][Full Text] [Related]
28. Gamma-aminobutyric acid-B limbic encephalitis and asystolic cardiac arrest: a case report.
Ovens CA; Jayamanne A; Duggins A
J Med Case Rep; 2017 Dec; 11(1):361. PubMed ID: 29287596
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and long-term follow-up of seven cases of anti-GABABR encephalitis in patients of Han Chinese descent.
Zeng W; Cao L; Zheng J; Yu L
Neurol Sci; 2020 Feb; 41(2):373-378. PubMed ID: 31659584
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine tumour metastatic brain disease during immunosuppressive treatment for paraneoplastic GABA
André A; Félix A; Shamasna M; Nzwalo H; Basílio C
J Neuroimmunol; 2017 Sep; 310():66-68. PubMed ID: 28778447
[TBL] [Abstract][Full Text] [Related]
31. Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis.
Kim TJ; Lee ST; Shin JW; Moon J; Lim JA; Byun JI; Shin YW; Lee KJ; Jung KH; Kim YS; Park KI; Chu K; Lee SK
J Neuroimmunol; 2014 May; 270(1-2):45-50. PubMed ID: 24662003
[TBL] [Abstract][Full Text] [Related]
32. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series.
Dogan Onugoren M; Deuretzbacher D; Haensch CA; Hagedorn HJ; Halve S; Isenmann S; Kramme C; Lohner H; Melzer N; Monotti R; Presslauer S; Schäbitz WR; Steffanoni S; Stoeck K; Strittmatter M; Stögbauer F; Trinka E; von Oertzen TJ; Wiendl H; Woermann FG; Bien CG
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):965-72. PubMed ID: 25300449
[TBL] [Abstract][Full Text] [Related]
33. Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.
Joubert B; Kerschen P; Zekeridou A; Desestret V; Rogemond V; Chaffois MO; Ducray F; Larrue V; Daubail B; Idbaih A; Psimaras D; Antoine JC; Delattre JY; Honnorat J
JAMA Neurol; 2015 Oct; 72(10):1163-9. PubMed ID: 26280228
[TBL] [Abstract][Full Text] [Related]
34. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome.
Bien CG; Mirzadjanova Z; Baumgartner C; Onugoren MD; Grunwald T; Holtkamp M; Isenmann S; Kermer P; Melzer N; Naumann M; Riepe M; Schäbitz WR; von Oertzen TJ; von Podewils F; Rauschka H; May TW
Eur J Neurol; 2017 Jan; 24(1):175-186. PubMed ID: 27786401
[TBL] [Abstract][Full Text] [Related]
35. GABA
Schumacher H; Meyer T; Prüss H
BMC Neurol; 2019 Mar; 19(1):41. PubMed ID: 30871492
[TBL] [Abstract][Full Text] [Related]
36. Anti-GABAB receptor encephalitis associated with combined small cell lung carcinoma.
Chao CH; Chu CC; Wei YC; Tseng JR; Chang HS
J Neuroimmunol; 2021 Nov; 360():577705. PubMed ID: 34478989
[TBL] [Abstract][Full Text] [Related]
37. Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis.
Casault C; Alikhani K; Pillay N; Koch M
J Neuroimmunol; 2015 Dec; 289():84-6. PubMed ID: 26616875
[TBL] [Abstract][Full Text] [Related]
38. Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super-refractory status epilepticus (NORSE) in a deployed U.S. soldier.
Hainsworth JB; Shishido A; Theeler BJ; Carroll CG; Fasano RE
Epileptic Disord; 2014 Dec; 16(4):486-93. PubMed ID: 25465280
[TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics of Anti-GABA-B Receptor Encephalitis.
Zhu F; Shan W; Lv R; Li Z; Wang Q
Front Neurol; 2020; 11():403. PubMed ID: 32508739
[No Abstract] [Full Text] [Related]
40. [Paraneoplastic anti-gamma aminobutyric acid (GABA)
Akiyama N; Miwa Y; Umeda Y; Tanaka K; Oyake M; Fujita N
Rinsho Shinkeigaku; 2020 Dec; 60(12):869-873. PubMed ID: 33229837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
